Showing results (131-140 of 170) with videos related to
Sort By:
Pageof 17
The Journal of Biological Chemistry|May 9, 2015
The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in VitroJordan M Spatz, Marc N Wein, Jonathan H Gooi, et al.The Journal of Biological Chemistry|August 20, 2016
Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone MassEmma C Walker, Rachelle W Johnson, Yifang Hu, et al.Bone|April 5, 2008
Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized ratsJulie F McManus, Rachel A Davey, Helen E Maclean, et al.Cancer Research|June 3, 2005
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell lineJohn T Price, Julian M W Quinn, Natalie A Sims, et al.Development (Cambridge, England)|January 13, 2016
Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossificationStephen Tonna, Ingrid J Poulton, Farzin Taykar, et al.Blood|August 18, 2010
Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCsIngrid G Winkler, Natalie A Sims, Allison R Pettit, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 21, 2012
EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repairAgnieszka Arthur, Romana A Panagopoulos, Lachlan Cooper, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaAgatha Labrinidis, Peter Diamond, Sally Martin, et al.The Journal of Clinical Investigation|March 25, 2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceMaya Kansara, Michael Tsang, Laurent Kodjabachian, et al.Pageof 17